Updated Results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) Trial.
      Google Scholar   
Citation:
Ann Oncol
Year:
2026
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
15
Parents:
None
Children:
None
Program:
CCP
Primary Committee:
Symptom Inter
Sec. Committees:
Breast    
Pharmas:
 
Grants:
UG1CA189823, U24CA196171; ECOG-ACRIN - UG1CA189828; SWOG -UG1CA189974, U10CA180888; NRG Oncology - U10CA180868, UG1CA189867; CCTG - CA180863 and 707213; Dutch Cancer Society, The Netherlands (KaWeFis Batch7/7723); Rising Tide Foundation for Clinical Cancer Research (CCR-15-120; CCR-20-200; CCR-24-150), Swiss Cancer League (KLS-3361-02), Breast Cancer Research Foundation (BCRF 24-011) and Gateway for Cancer Research (G-15-1900);  
Corr. Author:
 
Authors:
                                                                               
Networks:
LAPS-CO070, LAPS-MA036, LAPS-MN026, OH027   
Study
Alliance-A221405
Multiple Studies, or Legacy Studies in Alliance Study:
BIG 8-13, IBSCG 48-14
Phases:
N/A, N/A
Keywords: